Skip to main content

Table 4 Cost, effectiveness and incremental cost effectiveness ratio (ICER) of an additional birth dose of HB vaccine

From: Introduction of birth dose of hepatitis B virus vaccine to the immunization program in Ethiopia: an economic evaluation

Strategy Cost (US$) Incremental costs Effects (DALYs averted) Incremental effects (DALYs averted) ICER
Without birth dose 4.0243   0.001417   
With birth dose 4.3538 0.3295 0.004117 0.00300 110